NanoBlood LLC is dedicated to the development of a safe alternative to RBC transfusion built on the high therapeutic index of nano red blood cell (nRBC) in promoting blood flow and oxygen delivery with neurovascular protective efficacies, and the reduction of mortality and morbidity of the following unmet medical needs world wide.
Blood Transfusion
Read more......nRBC is being developed as a blood substitute to reduce the incidence of poor clinical outcomes from the transfusion of "aged" or "old" RBC.
Stroke
Read more......nRBC is being developed as a universal stroke drug to expand the current 2-3% of ischemic stroke patients treated with tPA to more than 30% and also to serve as a beneficial treatment for all stroke patients, ischemic and hemorrhagic, during the "golden hour".
Trauma
Read more......nRBC in being developed as a safe alternative to banked RBC transfusion while expanding the supply of resuscitation fluids available to hemorrhagic trauma patieints by making use of wasted outdated blood for patients suffering from trauma.
Traumatic Brain Injury
Read more......nRBC is being developed to treat traumatic brain injury complicated with hypotension as an orphan indication.
Sickle Cell Disease
Read more......nRBC is being developed for conjunctive use with current treatments of RBC transfusion and hydroxyurea therapy to the further reduce stroke, acute chest syndrome and painful vaso-occursive crisis due to chronic hemolysis in sickle cell patients.